Aiming to increase access to recommended treatments for COVID-19, WHO today added tocilizumab, a monoclonal antibody,...
Read moreReview of development program led to reassessment of benefit-risk ratio in all four potential indications for...
Read moreVabysmo (faricimab-svoa) targets and inhibits two disease pathways that drive neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME)...
Read moreBayer today announced Christine Roth as the new Head of the Oncology Strategic Business Unit at...
Read moreNuvaxovid™ is the first protein-based COVID-19 vaccine to receive provisional approval for distribution in New Zealand...
Read moreSanofi today unveiled a new bold and unifying corporate brand that supports the modernization and transformation...
Read moreFDA has approved Enjaymo (sutimlimab-jome) infusion to decrease the need for red blood cell transfusion due to hemolysis...
Read moreAmneal announced that the FDA accepted Amneal’s 505(b)(2) NDA for a newly licensed dihydroergotamine (DHE) prefilled...
Read moreargenx SE announced it will regain worldwide rights to its anti-CD70 antibody cusatuzumab from Cilag GmbH...
Read moreU.S. FDA Accepts PharmaEssentia’s BLA Resubmission for ropeginterferon alfa-2b-njft for the Treatment of Polycythemia Vera
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.